Role of Exosomes and Exosomal MicroRNAs in Hepatocellular Carcinoma: Potential in Diagnosis and Antitumour Treatments (Review)

Overview

Journal Int J Mol Med

Specialty Genetics

Date 2018 Jan 13

PMID 29328436

Citations 40

Authors

Jing-Hua Pan

Hong Zhou

Xiao-Xu Zhao

Hui Ding

Wei Li

Li Qin

Yun-Long Pan

Affiliations

Soon will be listed here.

Abstract

Communication between hepatocellular carcinoma (HCC) cells and their environment is essential for the development and progression of HCC. Exosomes, which are microvesicles secreted by a number of cell types, are carriers of intercellular information and regulate the tumour microenvironment. Studies have demonstrated that exosomes are involved in the communication between HCC cells, endothelial cells and stem cells, and that they serve important roles in the metastasis and invasion, immune evasion and immunotherapy of HCC. In addition, the mechanism of HCC‑derived exosome‑mediated microRNA (miRNA) transfer is important in the environmental modulation of HCC growth and progression. As exosomes can be used for detecting and monitoring HCC, they can potentially serve as specific biomarkers for early‑stage tumours and the tumour metastasis of HCC. Moreover, mesenchymal stem cell‑derived exosomes can be transfected with miRNAs to inhibit HCC development. Therefore, as nucleic acid delivery vehicles, exosomes show a tremendous potential for effective treatment against HCC. In the present review, recent advances in our understanding of the source, composition and function of exosomes in HCC, and their potential value in the early diagnosis and treatment of HCC, are summarized.

Citing Articles

Non-destructive and efficient method for obtaining miRNA information in cells by artificial extracellular vesicles.

Maeda F, Adachi S, Natsume T Sci Rep. 2023; 13(1):22231.

PMID: 38097629 PMC: 10721859. DOI: 10.1038/s41598-023-48995-5.

Exosome Cargos as Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma.

Zeng Y, Hu S, Luo Y, He K Pharmaceutics. 2023; 15(9).

PMID: 37765333 PMC: 10537613. DOI: 10.3390/pharmaceutics15092365.

Potential role of human umbilical cord stem cells-derived exosomes as novel molecular inhibitors of hepatocellular carcinoma growth.

ElBadre H, El-Deek S, Karam-Allah Ramadan H, Elbadr M, Sabry D, Ahmed N Apoptosis. 2023; 28(9-10):1346-1356.

PMID: 37338718 PMC: 10425301. DOI: 10.1007/s10495-023-01863-z.

Serum Exosome-Derived piRNAs Could Be Promising Biomarkers for HCC Diagnosis.

Rui T, Wang K, Xiang A, Guo J, Tang N, Jin X Int J Nanomedicine. 2023; 18:1989-2001.

PMID: 37077942 PMC: 10108868. DOI: 10.2147/IJN.S398462.

The Role of miRNAs, circRNAs and Their Interactions in Development and Progression of Hepatocellular Carcinoma: An Approach.

Ishaq Y, Ikram A, Alzahrani B, Khurshid S Genes (Basel). 2023; 14(1).

PMID: 36672755 PMC: 9858589. DOI: 10.3390/genes14010013.

References

Li Y, Zhang L, Liu F, Xiang G, Jiang D, Pu X . Identification of endogenous controls for analyzing serum exosomal miRNA in patients with hepatitis B or hepatocellular carcinoma. Dis Markers. 2015; 2015:893594. PMC: 4357047. DOI: 10.1155/2015/893594. View

Gramantieri L, Ferracin M, Fornari F, Veronese A, Sabbioni S, Liu C . Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Res. 2007; 67(13):6092-9. DOI: 10.1158/0008-5472.CAN-06-4607. View

Ko S, Yip H, Zhen Y, Lee C, Lee C, Huang C . Adipose-Derived Mesenchymal Stem Cell Exosomes Suppress Hepatocellular Carcinoma Growth in a Rat Model: Apparent Diffusion Coefficient, Natural Killer T-Cell Responses, and Histopathological Features. Stem Cells Int. 2015; 2015:853506. PMC: 4545422. DOI: 10.1155/2015/853506. View

Zhou W, Fong M, Min Y, Somlo G, Liu L, Palomares M . Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis. Cancer Cell. 2014; 25(4):501-15. PMC: 4016197. DOI: 10.1016/j.ccr.2014.03.007. View

Johnstone R, Adam M, Hammond J, Orr L, Turbide C . Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). J Biol Chem. 1987; 262(19):9412-20. View

Soung Y, Nguyen T, Cao H, Lee J, Chung J . Emerging roles of exosomes in cancer invasion and metastasis. BMB Rep. 2015; 49(1):18-25. PMC: 4914208. DOI: 10.5483/BMBRep.2016.49.1.239. View

Wang G, Zhu S, Gu Y, Chen Q, Liu X, Fu H . MicroRNA-145 and MicroRNA-133a Inhibited Proliferation, Migration, and Invasion, While Promoted Apoptosis in Hepatocellular Carcinoma Cells Via Targeting FSCN1. Dig Dis Sci. 2015; 60(10):3044-52. DOI: 10.1007/s10620-015-3706-9. View

Tanaka Y, Kamohara H, Kinoshita K, Kurashige J, Ishimoto T, Iwatsuki M . Clinical impact of serum exosomal microRNA-21 as a clinical biomarker in human esophageal squamous cell carcinoma. Cancer. 2012; 119(6):1159-67. DOI: 10.1002/cncr.27895. View

Wang S, Shen Y, Li J, Xiang Z, Fan W, Chen L . [Experimental studies on anti-mouse hepatocellular carcinoma effects of cisplatin combined with exosomes]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2009; 25(1):49-52. View

10.

Viaud S, Ploix S, Lapierre V, Thery C, Commere P, Tramalloni D . Updated technology to produce highly immunogenic dendritic cell-derived exosomes of clinical grade: a critical role of interferon-γ. J Immunother. 2010; 34(1):65-75. DOI: 10.1097/CJI.0b013e3181fe535b. View

11.

Bandiera S, Pfeffer S, Baumert T, Zeisel M . miR-122--a key factor and therapeutic target in liver disease. J Hepatol. 2014; 62(2):448-57. DOI: 10.1016/j.jhep.2014.10.004. View

12.

Street J, Barran P, Mackay C, Weidt S, Balmforth C, Walsh T . Identification and proteomic profiling of exosomes in human cerebrospinal fluid. J Transl Med. 2012; 10:5. PMC: 3275480. DOI: 10.1186/1479-5876-10-5. View

13.

Kogure T, Lin W, Yan I, Braconi C, Patel T . Intercellular nanovesicle-mediated microRNA transfer: a mechanism of environmental modulation of hepatocellular cancer cell growth. Hepatology. 2011; 54(4):1237-48. PMC: 3310362. DOI: 10.1002/hep.24504. View

14.

Whiteside T . Immune modulation of T-cell and NK (natural killer) cell activities by TEXs (tumour-derived exosomes). Biochem Soc Trans. 2013; 41(1):245-51. PMC: 3721347. DOI: 10.1042/BST20120265. View

15.

Yang Y, Wang F, Xiao J, Song Y, Zhao Y, Cao Y . MiR-222 overexpression promotes proliferation of human hepatocellular carcinoma HepG2 cells by downregulating p27. Int J Clin Exp Med. 2014; 7(4):893-902. PMC: 4057838. View

16.

Bobrie A, Thery C . Exosomes and communication between tumours and the immune system: are all exosomes equal?. Biochem Soc Trans. 2013; 41(1):263-7. DOI: 10.1042/BST20120245. View

17.

Wang H, Hou L, Li A, Duan Y, Gao H, Song X . Expression of serum exosomal microRNA-21 in human hepatocellular carcinoma. Biomed Res Int. 2014; 2014:864894. PMC: 4052145. DOI: 10.1155/2014/864894. View

18.

Harding C, Heuser J, Stahl P . Receptor-mediated endocytosis of transferrin and recycling of the transferrin receptor in rat reticulocytes. J Cell Biol. 1983; 97(2):329-39. PMC: 2112509. DOI: 10.1083/jcb.97.2.329. View

19.

Wei J, Lv L, Wan Y, Cao Y, Li G, Lin H . Vps4A functions as a tumor suppressor by regulating the secretion and uptake of exosomal microRNAs in human hepatoma cells. Hepatology. 2014; 61(4):1284-94. PMC: 4511093. DOI: 10.1002/hep.27660. View

20.

Varnholt H, Drebber U, Schulze F, Wedemeyer I, Schirmacher P, Dienes H . MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma. Hepatology. 2008; 47(4):1223-32. DOI: 10.1002/hep.22158. View